BackMonopar Therapeutics Overview
Monopar Therapeutics Inc

Monopar Therapeutics Target Price

Analysts' average 12-month price target for Monopar Therapeutics is $120.

Get informed when a big investor buys or sells

+ Follow

Share Price

$116.28

Average Target Price

$120.783.9% upside

9 analysts in the last 4 months

High: $133 | Low: $105

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-17Morgan StanleyMaxwell Skor$13011.8% upsideOpen
2026-08-13Barclays$12810.1% upsideOpen
2026-08-13Cantor FitzgeraldKristen Kluska$1192.3% upsideOpen
2026-08-12BTIGJeet Mukherjee$13314.4% upsideOpen
2026-07-23UBS$1257.5% upsideOpen
2026-07-22H.C. Wainwright$1257.5% upsideOpen
2026-06-30BTIG$1170.6% upsideOpen
2026-06-29UBS$1059.7% downsideOpen
2026-06-02Piper Sandler$1059.7% downsideOpen
2026-01-09Morgan StanleyMaxwell Skor$1151.1% downsideOpen
2025-11-14Raymond JamesChris Raymond$1235.8% upsideOpen
2025-10-13BarclaysEtzer Darout$1257.5% upsideOpen
2025-10-06Raymond James$14222.1% upsideOpen
2025-10-02Oppenheimer$1151.1% downsideOpen
2025-09-29H.C. Wainwright$1059.7% downsideOpen
2025-09-25Chardan CapitalKeay Nakae$8526.9% downsideOpen
2025-09-25Piper SandlerBiren Amin$9518.3% downsideOpen
2025-09-24BTIG$10410.6% downsideOpen
2025-09-09BTIGJeet Mukherjee$8725.2% downsideOpen
2025-09-02Raymond James$8031.2% downsideOpen
2025-08-26H.C. Wainwright$7039.8% downsideOpen
2024-11-19UBSJustin Walsh$3768.2% downsideOpen
2024-11-11H.C. WainwrightSean Lee$2281.1% downsideOpen

Monopar Therapeutics (MNPR) FAQ

The latest target price for MNPR is $120. Investors often review this figure alongside Monopar Therapeutics's historical trend and sector peers before judging valuation or financial health.

Monopar Therapeutics trades near $116.28 while the consensus target sits at $120 (3.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting MNPR's target price ($120), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Monopar Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.